The bacterium, Candidatus Liberibacter asiaticus, cannot be cultured in the laboratory, making it extraordinarily difficult to study. To overcome this obstacle, the research team turned to two phylogenetically related culturable relatives: Liberibacter crescens and Sinorhizobium fredii. Using these model organisms, the researchers characterized a novel antimicrobial peptide called DcGrAMP1, which is produced by the insect vector in response to bacterial infection.

Structural modeling revealed that the monomeric form of DcGrAMP1 adopts a linear, extended conformation devoid of alpha-helices and beta-sheets. Native-PAGE analysis showed that the peptide forms oligomers exceeding 45 kilodaltons in bacterial cells, and that bacterial infection significantly promotes this oligomerization. Structure prediction identified three residues—Arg26, Arg31, and Tyr35—as critical for oligomer formation. When the researchers substituted alanine at positions 26 and 31, the resulting double mutant failed to oligomerize and displayed markedly reduced antibacterial activity, confirming the essential role of these residues in the peptide’s function.

Further experiments demonstrated that DcGrAMP1 kills bacteria by disrupting their cell membranes. Viability assays showed concentration-dependent lethality, with minimum inhibitory concentrations between 20 and 40 micromolar. Scanning electron microscopy revealed membrane disruption and wrinkling in treated cells, and assays detecting cytoplasmic leakage confirmed membrane damage. Notably, the peptide retained most of its activity even after 18 hours at 60 degrees Celsius, a property that distinguishes it from many heat-sensitive antibiotics and suggests durability under field conditions.

The researchers then investigated how DcGrAMP1 interacts with bacterial membrane proteins. Yeast two-hybrid screening identified a specific interaction with ZnuA, a periplasmic zinc-binding protein that forms part of a high-affinity zinc uptake system. Isothermal titration calorimetry revealed strong binding between the peptide and ZnuA, with a dissociation constant in the nanomolar range. Western blot analysis showed that co-expression of DcGrAMP1 with ZnuA resulted in cleavage of the zinc transporter, producing a characteristic fragment pattern. Mutating a single aspartate residue in ZnuA abolished cleavage, pinpointing the exact site where the peptide cuts its target.

Time-course experiments revealed that cleavage occurs within minutes of peptide exposure and intensifies over three hours. The researchers also found that the peptide’s bactericidal activity depends on this cleavage: variants of DcGrAMP1 that could not oligomerize showed reduced antibacterial activity, and variants that could not cleave ZnuA showed reduced bactericidal activity. These results suggest that oligomerization and proteolysis work together in a coordinated mechanism, with oligomerization enabling the peptide to reach and disrupt the membrane while cleavage of ZnuA delivers the final blow.

The team then explored how bacterial infection triggers DcGrAMP1 expression. Reporter assays in bacterial cells showed that infection significantly activated the DcGrAMP1 promoter, and yeast one-hybrid analysis confirmed that a transcription factor binds directly to the promoter region. Mutating the binding site abolished activation, confirming the specificity of this regulatory mechanism. These findings reveal how the peptide’s production is precisely controlled in response to bacterial challenge.

Finally, the researchers tested whether DcGrAMP1 could protect plants from citrus greening disease. In greenhouse trials, plants treated with the peptide showed significantly reduced bacterial titers compared to untreated controls. Plants expressing the peptide also displayed reduced disease symptoms. These results suggest that DcGrAMP1 could serve as a durable antimicrobial agent for field applications against the unculturable bacterium that causes citrus greening disease.

The study positions DcGrAMP1 as a novel antimicrobial weapon with a distinctive dual mechanism: oligomerization-dependent membrane disruption and site-specific proteolysis of a membrane zinc transporter. The remarkable thermal stability of the peptide, combined with its precision targeting, highlights its potential as a durable antimicrobial agent for field applications. The research also underscores the value of culturable Liberibacter relatives as model organisms for studying the biology of the bacterium that causes one of the world’s most destructive citrus diseases.

The discovery of DcGrAMP1 adds an important new branch to the growing catalog of insect antimicrobial peptides, which currently numbers more than 200 distinct molecules across insect species. These peptides have traditionally been sorted into structural families: cecropins, which are linear amphipathic alpha-helices lacking cysteine residues; defensins, which fold into a cysteine-stabilized alpha-helix and beta-sheet motif; proline-rich peptides; and glycine-rich peptides, defined by glycine content exceeding roughly half of their sequence. What sets DcGrAMP1 apart from most previously characterized members of these families is that its antibacterial action does not stop at membrane pore formation. The conventional model for many insect antimicrobial peptides involves electrostatic attraction to negatively charged bacterial membranes followed by insertion and pore assembly, a mechanism that is broadly disruptive but relatively indiscriminate. In contrast, DcGrAMP1 combines this membrane-directed activity with a second, highly specific step: the direct cleavage of a single periplasmic protein, ZnuA, on the target cell.

This dual mechanism may be particularly relevant to the challenge posed by phloem-limited bacteria such as Candidatus Liberibacter asiaticus. Because these organisms reside inside the plant’s nutrient-conducting sieve tubes and cannot yet be maintained on artificial media, conventional screening pipelines that rely on cultured pathogens have historically struggled to generate countermeasures against them. The field has responded with a diverse set of workarounds, each illuminating a different angle of attack. A stable antimicrobial peptide of 67 amino acids derived from the HLB-tolerant Australian finger lime, containing two predicted alpha-helical domains, has been shown to directly inhibit the bacterium in infected trees. Small-molecule inhibitors designed against two independent nutrient transport proteins, TcyA and Esbp, have been identified through structural simulation and validated biologically, illustrating the value of targeting the bacterium’s nutritional vulnerabilities. Spinach-derived defensin overexpression in citrus, phage-derived endolysin expression, and citrus papain-like cysteine proteases that cleave bacterial membrane proteins each represent additional strategies that have conferred meaningful resistance. A 14-residue peptide from a human gut microbiome-derived library, APP3-14, has even been shown to stabilize the MYC2 transcription factor of the jasmonate defense pathway, suppressing disease in both greenhouse and field settings. DcGrAMP1 now joins this arsenal, but with a mechanistic signature that appears to be genuinely novel: a peptide that behaves as a sequence-specific protease against a defined membrane protein of its bacterial target.

The zinc transporter ZnuA is a biologically logical target for such an attack. As the periplasmic component of a high-affinity zinc uptake system, ZnuA allows bacteria to scavenge this essential metal from environments where free zinc is scarce. In the nutrient-poor phloem sap that Candidatus Liberibacter asiaticus inhabits, metal acquisition is likely to be a rate-limiting step for growth and proliferation. By cleaving ZnuA specifically, DcGrAMP1 would not merely poke holes in the bacterial envelope but would simultaneously cripple a critical nutritional pathway, compounding the damage caused by membrane disruption. This kind of targeted, two-pronged attack may explain why the peptide achieves bactericidal effects at micromolar concentrations against organisms that have proven remarkably resilient to conventional approaches.

The regulatory circuitry controlling DcGrAMP1 expression also fits into a broader picture of insect innate immunity. When insects detect pathogens, conserved signaling cascades including Toll, IMD, JAK-STAT, and JNK-AP1 are activated, leading to the synthesis of antimicrobial peptides primarily in the fat body, the functional equivalent of the liver in these animals, from which they are secreted into the hemolymph to provide systemic protection. The finding that Candidatus Liberibacter asiaticus infection activates the JNK-AP1 pathway in the Asian citrus psyllid, thereby upregulating DcGrAMP1, places this peptide within a well-characterized stress-responsive framework. It also suggests that the psyllid’s immune system has evolved a specific countermeasure tuned to this particular pathogen, which coexists with the insect in a persistent-propagative manner, moving from midgut to hemolymph to salivary glands over the course of transmission.

From a practical standpoint, the thermal stability of DcGrAMP1 deserves emphasis. Many protein-based antimicrobials lose activity rapidly at elevated temperatures, which limits their usefulness in agricultural settings where field conditions can be hot and variable. The observation that this peptide retains most of its bactericidal activity after prolonged exposure to moderately elevated temperatures suggests that it could withstand real-world deployment more readily than heat-labile alternatives. Combined with its demonstrated suppression of bacterial titers in greenhouse trials, this property strengthens the case for further development.

The use of culturable Liberibacter relatives as surrogate models also merits attention. Because the target pathogen itself cannot be grown outside its host, the ability to study peptide-bacterium interactions in tractable organisms such as Liberibacter crescens and Sinorhizobium fredii provides a critical experimental bridge. This approach allowed the research team to map oligomerization, identify the specific residues required for assembly, pinpoint the cleavage site on ZnuA, and quantify binding affinity, all of which would have been far more difficult or impossible with the unculturable pathogen directly. As research into phloem-limited bacteria continues, such surrogate systems are likely to remain indispensable tools for dissecting molecular mechanisms before validation in the actual host-pathogen context.

Looking forward, several questions remain open. How DcGrAMP1 reaches the periplasmic space in sufficient quantities to effect cleavage, whether the peptide’s oligomeric state changes upon membrane contact, and how the bacterium might evolve resistance to this attack are all areas that will require further study. Nevertheless, the demonstration that an insect-derived glycine-rich peptide can function as a targeted protease against a specific membrane protein of an unculturable plant pathogen represents a meaningful conceptual advance in the effort to manage one of the world’s most destructive citrus diseases.

Subject of Research: DcGrAMP1 antimicrobial peptide mechanism

Article Title: Psyllid glycine-rich antimicrobial peptides oligomerize to directly cleave zinc transporter ZnuA on the membranes of citrus Huanglongbing pathogen

Article References: Peng, H., Bin, Y., Li, Y., Du, Y., Wang, C., Wang, S., & Wei, T. (2026). Psyllid glycine-rich antimicrobial peptides oligomerize to directly cleave zinc transporter ZnuA on the membranes of citrus Huanglongbing pathogen. Journal of Advanced Research. https://doi.org/10.1016/j.jare.2026.10.012

Image Credits: AI Generated

DOI: 10.1016/j.jare.2026.10.012

Keywords: DcGrAMP1, antimicrobial peptide, oligomerization, ZnuA cleavage, Liberibacter, membrane disruption, proteolysis, citrus greening, Psyllid, glycine-rich, antimicrobial, peptides